Indefinite Delivery Contract 75F40121D00033
- Not listed
- The Federal Contract IDV award is a single-award Indefinite Delivery Contract valued at up to $3,446,837.42 for a period of performance from May 16, 2023 to May 16, 2026. The contract was awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Syneos Health Research & Insights LLC. The contract aims to provide the FDA with access to healthcare practitioner prescribing practices data. The original solicitation was a combined synopsis/solicitation for commercial items,...
- This federal Indefinite Delivery Contract (IDC) was awarded by the U.S. Food and Drug Administration (FDA), a civilian agency, to Integrated Behavioral Health, Inc., a for-profit subchapter S corporation. The $10 million IDC provides data licensing, data acquisition and management, and drug use surveillance services to support the FDA's post-marketing surveillance of non-medical use of pharmaceuticals and use of illicit drug substances. Two task orders have been issued under this IDC. The...
- The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) valued at up to $6,785,460 through September 30, 2029, awarded by the U.S. Food and Drug Administration (FDA) to the Missouri Department of Mental Health's Division of Behavioral Health. The contract is focused on tobacco retail compliance and enforcement inspections in the state of Missouri, including recruiting and training underage purchasers, coordinating undercover buy operations at tobacco retailers,...
- The federal contract IDV award with ID 75F40118D10007 is an Indefinite Delivery Contract (IDC) issued by the Food and Drug Administration (FDA), a civilian agency, to Syneos Health Research & Insights LLC, a for-profit limited liability company. The contract has a ceiling value of $2,947,016.61 and a period of performance running from the award date of May 16, 2018 to the ultimate completion date of May 16, 2023. The contract is for "ACCESS TO HEALTH CARE PRACTITIONER PRESCRIBING...
- The Colorado Department of Public Health & Environment (CDPHE) was awarded a single-award Indefinite Delivery Contract (IDC) by the Food and Drug Administration (FDA) to conduct tobacco retail inspections in Colorado. The contract has a ceiling value of $8,367,299.00 and runs through September 29, 2029. Under this IDC, CDPHE has been issued two delivery orders to date: a $1,043,040.14 order for tobacco retail inspections through 2029, and a $1,525,072.40 order for a one-year period of...
- This Indefinite Delivery Contract (IDC) was awarded by the U.S. Food and Drug Administration (FDA), a civilian federal agency, to Iqvia Government Solutions Inc., a for-profit organization specializing in healthcare data, analytics, and research services. The contract has a ceiling value of $4,463,492.67 and a period of performance extending to July 14, 2030. The primary objective of this contract is to provide the FDA with comprehensive hospital inpatient and emergency department drug...
- The Department of Health and Human Services' Food and Drug Administration (FDA) awarded an Indefinite Delivery Contract (IDC) valued at $45 million to Iqvia Government Solutions Inc., a leading provider of healthcare data, analytics, and related services to federal agencies. The contract enables the FDA to issue task orders for access to outpatient prescription and patient-level drug utilization data to support its regulatory programs and post-market drug safety monitoring initiatives over a...
- This federal contract IDV was awarded by the U.S. Department of Health and Human Services Food and Drug Administration (FDA) to Booz Allen Hamilton Inc., a leading provider of management, technology, and engineering services to the U.S. government. The indefinite delivery contract, valued at up to $19,998,000, is for scientific studies and analysis in support of the FDA's Center for Drug Evaluation and Research (CDER) priority programs. It is a multiple award contract without any set-aside...
- This federal contract IDV award from the Department of Health and Human Services' Food and Drug Administration (HHS FDA) to We Pharma, Inc. (doing business as WEP Clinical) is for the provision of pharmaceutical products and emergency delivery services to support the FDA's research, regulatory, and operational activities. The $6 million, single-award IDV contract, awarded in June 2021, tasks the prime contractor, a self-certified small disadvantaged business, with supplying currently marketed...
- The federal contract IDV award is an Indefinite Delivery Contract with a ceiling value of $10,000,000 issued by the Food and Drug Administration (FDA) to the Lovelace Biomedical Research Institute, a non-profit contract research organization. The contract aims to procure preclinical research services and support the development of treatments and cures for various diseases and conditions, including respiratory diseases, HIV/AIDS, pain disorders, COVID-19 medical countermeasures, infectious...
- 75F40121D00033Indefinite Delivery Contract
- 4Federal Contract Awards
The federal contract IDV award, valued up to $10 million, was issued by the U.S. Food and Drug Administration (FDA) to the Denver Health and Hospital Authority (Denver Health), a U.S. local/state government entity and healthcare provider. The contract provides data resources to support the FDA's post-marketing surveillance of nonmedical use of pharmaceuticals and illicit drug use. Under this IDV, Denver Health has been awarded multiple firm fixed-price delivery orders. These include a $205,010 contract for a survey on nonmedical use of prescription drugs, a $630,211 contract for an online panel survey to assess the prevalence and experiences of falsified/unapproved pharmaceuticals, and a $695,889 contract for broader data collection and analytics services to support the FDA's pharmaceutical safety surveillance programs. The contracts do not have any set-aside designations and will be performed in Denver, Colorado and Silver Spring, Maryland through September 2024, 2025, and 2026 respectively. Denver Health, as a major healthcare provider serving underserved populations, has significant expertise in public health data initiatives and federal contracting across the Department of Health and Human Services.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00004 | Other Administrative Action | $0 | 12/19/23 | |
| P00003 | Other Administrative Action | $0 | 6/29/23 | |
| P00002 | Supplemental Agreement for work within scope | $0 | 9/19/22 | |
| P00001 | Supplemental Agreement for work within scope | $0 | 12/1/21 | |
| Not listed | Not listed | $0 | 9/27/21 |
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
Delivery Order 75F40121D00033-75F40122F19002 | Denver Health And Hospital Authority | $630.2k | 8/31/22 | 9/28/26 | 4/29/25 | |
Delivery Order 75F40121D00033-75F40124F19003 | Denver Health And Hospital Authority | $205.0k | 1/30/24 | 9/1/24 | 1/30/24 | |
Delivery Order 75F40121D00033-75F40126F19004 | Denver Health And Hospital Authority | $309.3k | 12/19/25 | 12/16/26 | 12/19/25 | |
Delivery Order 75F40121D00033-75F40121F19001 | Denver Health And Hospital Authority | $695.9k | 9/30/21 | 9/29/26 | 4/29/25 |